Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma

References

• Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, . An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004;54:131–49; quiz 82–4.
   PubMed Web of Science ®Google Scholar
• Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma: Results of a meta-analysis. Melanoma Res 2000;10:81–92.
   PubMed Web of Science ®Google Scholar
• Harpole DH, Jr., Johnson CM, Wolfe WG, George SL, Seigler HF. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992;103:743–8; Discussion 8–50.
   PubMed Web of Science ®Google Scholar
• Petersen RP, Hanish SI, Haney JC, Miller CC, 3rd, Burfeind WR, Jr., Tyler DS, . Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007;133:104–10.
   PubMed Web of Science ®Google Scholar
• Tafra L, Dale PS, Wanek LA, Ramming KP, Morton DL. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. Thorac Cardiovasc Surg 1995;110:119–28; Discussion 29.
   Google Scholar
• Conill C, Gimferrer JM, Marruecos J, Domingo-Domenech J, Vilella R, Catalan M, . Clinical outcome after surgical resection of lung metastases from melanoma. Clin Transl Oncol 2007;9:48–52.
   PubMedGoogle Scholar
• Hillner BE, Kirkwood JM, Agarwala SS. Burden of illness associated with metastatic melanoma: An audit of 100 consecutive referral center cases. Cancer 2001;91:1814–21.
   PubMedGoogle Scholar
• Jost LM, Jelic S, Purkalne G. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma. Ann Oncol 2005;16(Suppl 1):i66–8.
   PubMedGoogle Scholar
• Dummer R, Panizzon R, Bloch PH, Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology 2005;210:39–44.
   PubMed Web of Science ®Google Scholar
• Garbe C. A rational approach to the follow-up of melanoma patients. Recent results in cancer research. Fortsch Krebsforsch 2002;160:205–15.
   PubMedGoogle Scholar
• Ollila DW. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol 2006;7:919–24.
   PubMed Web of Science ®Google Scholar
• Young SE, Martinez SR, Essner R. The role of surgery in treatment of stage IV melanoma. J Surgical Oncol 2006;94:344–51.
   PubMed Web of Science ®Google Scholar
• Ollila DW, Caudle AS. Surgical management of distant metastases. Surg Oncol Clin N Am 2006;15:385–98.
   PubMedGoogle Scholar
• Mosca PJ, Teicher E, Nair SP, Pockaj BA. Can surgeons improve survival in stage IV melanoma? J Surg Oncol 2008;97:462–8.
   PubMedGoogle Scholar
• Neuman HB, Patel A, Hanlon C, Wolchok JD, Houghton AN, Coit DG. Stage-IV melanoma and pulmonary metastases: Factors predictive of survival. Ann Surg Oncol 2007;14:2847–53.
   PubMedGoogle Scholar
• Leo F, Cagini L, Rocmans P, Cappello M, Geel AN, Maggi G, . Lung metastases from melanoma: When is surgical treatment warranted? Br J Cancer 2000;83:569–72.
   PubMed Web of Science ®Google Scholar
• Chevalier J, Bonastre J, Avril MF. The economic burden of melanoma in France: Assessing healthcare use in a hospital setting. Melanoma Res 2008;18:40–6.
   PubMedGoogle Scholar
• Harris MT, Berlangieri SU, Cebon JS, Davis ID, Scott AM. Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma. Mol Imaging Biol 2005;7:304–8.
   PubMedGoogle Scholar
• Dalrymple-Hay MJ, Rome PD, Kennedy C, Fulham M, McCaughan BC. Pulmonary metastatic melanoma – the survival benefit associated with positron emission tomography scanning. Eur J Cardiothorac Surg 2002;21:611–4; Discussion 4–5.
   PubMedGoogle Scholar
• Essner R, Belhocine T, Scott AM, Even-Sapir E. Novel imaging techniques in melanoma. Surg Oncol Clin N Am 2006;15:253–83.
   PubMedGoogle Scholar
• Krug B, Crott R, Lonneux M, Baurain JF, Pirson AS, Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: Systematic review. Radiology 2008;249:836–44.
   PubMed Web of Science ®Google Scholar
• Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, . Evidence and interdisciplinary consense-based German guidelines: Diagnosis and surveillance of melanoma. Melanoma Res 2007;17:393–9.
   PubMed Web of Science ®Google Scholar
• Choi EA, Gershenwald JE. Imaging studies in patients with melanoma. Surg Oncol Clin N Am 2007;16:403–30.
   PubMedGoogle Scholar
• Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, . Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008;49:480–508.
   PubMed Web of Science ®Google Scholar
• Dummer R, Hauschild A, Jost L. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19(Suppl 2):ii86–8.
   PubMedGoogle Scholar
• Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397–409.
   PubMed Web of Science ®Google Scholar
• Ollila DW, Hsueh EC, Stern SL, Morton DL. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999;71:209–13.
   PubMed Web of Science ®Google Scholar
• Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997;113:37–49.
   PubMedGoogle Scholar
• Cashin RP, Lui P, Machado M, Hemels ME, Corey-Lisle PK, Einarson TR. Advanced cutaneous malignant melanoma: A systematic review of economic and quality-of-life studies. Value Health 2008;11:259–71.
   PubMedGoogle Scholar
• Mooney MM, Mettlin C, Michalek AM, Petrelli NJ, Kraybill WG. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: A cost-effectiveness analysis. Cancer 1997;80:1052–64.
   PubMedGoogle Scholar
• Sterftetafels 2006: Verwachte levensduur, sterftekans en overlevingskans. 2006.
   Google Scholar
• Nashan D, Muller ML, Grabbe S, Wustlich S, Enk A. Systemic therapy of disseminated malignant melanoma: An evidence-based overview of the state-of-the-art in daily routine. J Eur Acad Dermatol Venereol 2007;21:1305–18.
   PubMed Web of Science ®Google Scholar
• Tawbi HA, Kirkwood JM. Management of metastatic melanoma. Semin Oncol 2007;34:532–45.
   PubMed Web of Science ®Google Scholar
• Lui P, Cashin R, Machado M, Hemels M, Corey-Lisle PK, Einarson TR. Treatments for metastatic melanoma: Synthesis of evidence from randomized trials. Cancer Treat Review 2007;33:665–80.
   PubMed Web of Science ®Google Scholar
• Tarhini AA, Agarwala SS. Cutaneous melanoma: Available therapy for metastatic disease. Dermatol Ther 2006;19:19–25.
   PubMed Web of Science ®Google Scholar
• Eggermont AM, Kirkwood JM. Re-evaluating the role of dacarbazine in metastatic melanoma: What have we learned in 30 years? Eur J Cancer 2004;40:1825–36.
   PubMed Web of Science ®Google Scholar
• Cleemput I, Van Wilder P, Vrijens F, Huybrechts M, Ramaekers D. Guidelines for pharmacoeconomic evaluations in Belgium. KCE reports 78A. Brussels: Belgian Health Care Knowledge Centre; 2008.
   Google Scholar
• Krug B, Van Zanten A, Crott R, Pirson AS, Vander Borght T. Activity-based costing evaluation of a [18F]-fludeoxyglucose positron emission tomography study. Health Policy 2009 (in press).
   PubMedGoogle Scholar
• Pastorino U. History of the surgical management of pulmonary metastases and development of the International Registry. Semin Thorac Cardiovasc Surg 2002;14:18–28.
   PubMedGoogle Scholar
• Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: Implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007;14:1924–33.
   PubMed Web of Science ®Google Scholar
• Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, Corrie PG, . UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146:7–17.
   PubMedGoogle Scholar
• Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, . Evidence and interdisciplinary consensus-based German guidelines: Surgical treatment and radiotherapy of melanoma. Melanoma Res 2008;18:61–7.
   PubMed Web of Science ®Google Scholar
• Allen PJ, Coit DG. The surgical management of metastatic melanoma. Ann Surg Oncol 2002;9:762–70.
   PubMed Web of Science ®Google Scholar
• Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival. Br J Cancer 2002;87:151–7.
   PubMedGoogle Scholar
• Agnese DM, Abdessalam SF, Burak WE, Jr., Magro CM, Pozderac RV, Walker MJ. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003;134:542–7; Discussion 7–8.
   PubMed Web of Science ®Google Scholar
• Hengge UR, Wallerand A, Stutzki A, Kockel N. Cost-effectiveness of reduced follow-up in malignant melanoma. J Dtsch Dermatol Ges 2007;5:898–907.
   PubMedGoogle Scholar
• Basseres N, Grob JJ, Richard MA, Thirion X, Zarour H, Noe C, . Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France. Dermatology 1995;191:199–203.
   PubMedGoogle Scholar
• Zubeldia JM, Bednarczyk EM, Baker JG, Nabi HA. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases. Cancer Biother Radiopharm 2005;20:450–6.
   PubMedGoogle Scholar
• Park KC, Schwimmer J, Gambhir SS. Decision analysis for the cost-effective management of recurrent colorectal cancer. Ann Surg 2002;235:309–10; author reply 10.
   PubMedGoogle Scholar
• Belhocine TZ, Scott AM, Even-Sapir E, Urbain JL, Essner R. Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006;47:957–67.
   PubMed Web of Science ®Google Scholar
• Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol 2007;9:50–7.
   PubMedGoogle Scholar
• Reinhardt MJ, Joe AY, Jaeger U, Huber A, Matthies A, Bucerius J, . Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: Experience with 250 consecutive patients. J Clin Oncol 2006;24:1178–87.
   PubMed Web of Science ®Google Scholar
• Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004;139:961–6; Discussion 6–7.
   PubMedGoogle Scholar
• Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: A systematic review of published series. Annals Thorac Surg 2007;84:324–38.
   PubMed Web of Science ®Google Scholar
• Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: A 20-year experience. Annals Thorac Surg 1984;38:323–30.
   PubMed Web of Science ®Google Scholar
• Koodziejski L, Goralczyk J, Dyczek S, Duda K, Nabiaek T. The role of surgery in lung metastases. Eur J Surg Oncol 1999;25:410–7.
   PubMedGoogle Scholar
• Meyer T, Merkel S, Goehl J, Hohenberger W. Surgical therapy for distant metastases of malignant melanoma. Cancer 2000;89:1983–91.
   PubMed Web of Science ®Google Scholar
• Fletcher WS, Pommier RF, Lum S, Wilmarth TJ. Surgical treatment of metastatic melanoma. Am J Surg 1998;175:413–7.
   PubMed Web of Science ®Google Scholar
• Gorenstein LA, Putnam JB, Natarajan G, Balch CA, Roth JA. Improved survival after resection of pulmonary metastases from malignant melanoma. Annals Thorac Surg 1991;52:204–10.
   PubMed Web of Science ®Google Scholar
• Andrews S, Robinson L, Cantor A, DeConti RC. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control 2006;13:218–23.
   PubMedGoogle Scholar
• Hamm C, Verma S, Petrella T, Bak K, Charette M. Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review. Cancer Treat Review 2008;34:145–56.
   PubMed Web of Science ®Google Scholar
• Mottaghy FM, Sunderkotter C, Schubert R, Wohlfart P, Blumstein NM, Neumaier B, . Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma. Eur J Nucl Med Mol Imaging 2007;34:1355–64.
   PubMedGoogle Scholar